Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.
2.

Low levels of serum testosterone in middle-aged men impact pathological features of prostate cancer.

Llukani E, Katz BF, Agalliu I, Lightfoot A, Yu SS, Kathrins M, Lee Z, Su YK, Monahan Agnew K, McGill A, Eun DD, Lee DI.

Prostate Int. 2017 Mar;5(1):17-23. doi: 10.1016/j.prnil.2016.12.003. Epub 2017 Jan 12.

3.

The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy.

Porcaro AB, Caruso B, Terrin A, De Luyk N, Cacciamani G, Corsi P, Inverardi D, De Marchi D, Baldassarre R, Cerruto M, Ghimenton C, Brunelli M, Zecchini Antoniolli S, Petrozziello A, Artibani W.

Arch Ital Urol Androl. 2016 Mar 31;88(1):17-22. doi: 10.4081/aiua.2016.1.17.

4.

Does Calculated Free Testosterone Overcome Total Testosterone in Protecting From Sexual Symptom Impairment? Findings of a Cross-Sectional Study.

Boeri L, Capogrosso P, Ventimiglia E, Cazzaniga W, Pederzoli F, Moretti D, Dehò F, Montanari E, Montorsi F, Salonia A.

J Sex Med. 2017 Dec;14(12):1549-1557. doi: 10.1016/j.jsxm.2017.10.070.

PMID:
29198510
5.

Testosterone is associated with erectile dysfunction: a cross-sectional study in Chinese men.

Liao M, Huang X, Gao Y, Tan A, Lu Z, Wu C, Zhang Y, Yang X, Zhang H, Qin X, Mo Z.

PLoS One. 2012;7(6):e39234. doi: 10.1371/journal.pone.0039234. Epub 2012 Jun 21.

6.

Low circulating free and bioavailable testosterone levels as predictors of high-grade tumors in patients undergoing radical prostatectomy for localized prostate cancer.

Léon P, Seisen T, Cussenot O, Drouin SJ, Cattarino S, Compérat E, Renard-Penna R, Mozer P, Bitker MO, Rouprêt M.

Urol Oncol. 2015 Sep;33(9):384.e21-7. doi: 10.1016/j.urolonc.2014.11.010. Epub 2015 Jan 13.

PMID:
25595576
7.

Free testosterone correlated with erectile dysfunction severity among young men with normal total testosterone.

Huang YP, Liu W, Chen SF, Liu YD, Chen B, Deng CH, Lu MJ.

Int J Impot Res. 2019 Mar;31(2):132-138. doi: 10.1038/s41443-018-0090-y. Epub 2018 Oct 22.

PMID:
30349000
8.

Investigative clinical study on prostate cancer part IX and X: estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy.

Porcaro AB, Ghimenton C, Petrozziello A, Sava T, Migliorini F, Romano M, Caruso B, Cocco C, Antoniolli SZ, Lacola V, Rubilotta E, Monaco C.

Anticancer Res. 2012 Oct;32(10):4523-32.

PMID:
23060581
9.

Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer.

Schnoeller T, Jentzmik F, Rinnab L, Cronauer MV, Damjanoski I, Zengerling F, Ghazal AA, Schrader M, Schrader AJ.

World J Urol. 2013 Apr;31(2):253-9. doi: 10.1007/s00345-012-0902-5. Epub 2012 Jul 5.

PMID:
22763628
10.

Testosterone deficiency with erectile dysfunction in mongolian men.

Naidan N, Rivaad OE, Muukhai N, Janlav M.

World J Mens Health. 2013 Aug;31(2):170-5. doi: 10.5534/wjmh.2013.31.2.170. Epub 2013 Aug 31.

11.

Associations of pretreatment serum total testosterone measurements with pathology-detected Gleason score cancer.

Porcaro AB, Petrozziello A, Ghimenton C, Migliorini F, Sava T, Caruso B, Romano M, Cavalleri S, Artibani W.

Urol Int. 2014;93(3):269-78. doi: 10.1159/000354621. Epub 2013 Dec 11.

PMID:
24334919
12.

Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.

Kumar A, Samavedi S, Mouraviev V, Bates AS, Coelho RF, Rocco B, Patel VR.

J Robot Surg. 2017 Mar;11(1):37-45. doi: 10.1007/s11701-016-0606-8. Epub 2016 May 31.

PMID:
27245233
13.

Prospective comprehensive assessment of sexual function after retropubic non nerve sparing radical prostatectomy for localized prostate cancer.

Trinchieri A, Nicola M, Masini F, Mangiarotti B.

Arch Ital Urol Androl. 2005 Dec;77(4):219-23.

PMID:
16444937
14.

Preoperative hormonal pattern in patients undergoing radical prostatectomy due to prostate cancer.

García-Cruz E, Castañeda-Argáiz R, Carrión A, Alcover J, Sallent A, Leibar-Tamayo A, Romero-Otero J, Alcaraz A; Red Española de Investigación en Salud del Hombre (REISHO).

Actas Urol Esp. 2013 May;37(5):280-5. doi: 10.1016/j.acuro.2012.08.002. Epub 2012 Dec 13. English, Spanish.

PMID:
23246101
15.
16.
17.

[A preliminary study of serum free testosterone and testosterone secreting index in men with erectile dysfunction].

Xue JG, Lu ZL, Ning KQ, He Y, Ni LY, Wang Q, Huang J, Sun ZX, Huang XF, She YQ, Ge L, Zhang CB.

Zhonghua Nan Ke Xue. 2007 Dec;13(12):1098-101. Chinese.

PMID:
18284059
18.

Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population.

Mendez MH, Passoni NM, Pow-Sang J, Jones JS, Polascik TJ.

J Endourol. 2015 Oct;29(10):1193-8. doi: 10.1089/end.2014.0881. Epub 2015 Jul 13.

PMID:
26058496
19.
20.

Serum testosterone levels in diabetic men with and without erectile dysfunction.

Ghazi S, Zohdy W, Elkhiat Y, Shamloul R.

Andrologia. 2012 Dec;44(6):373-80. doi: 10.1111/j.1439-0272.2012.01292.x. Epub 2012 Apr 4.

PMID:
22471752

Supplemental Content

Support Center